Orla McGarvey, Lonza AG - Qepler Summits And Conferences

Orla McGarvey

Principal Group Leader, Drug Product Process Development
Lonza AG
Madrid, Spain
Lonza is one of the world's leading suppliers to the Pharma&Biotech and Specialty Ingredient markets with products that enhance your overall quality of life.

As a leader in Contract Development and Manufacturing, Lonza Pharma & Biotech is recognised for high quality service, global capacity, an innovative tech platform and extensive experience.

Lonza has a broad expertise in biologics, small molecules, bio-conjugates and cell & gene therapy, supporting pre-clinical stage through to commercialisation, for both drug substance and drug product. Orla McGarvey is Principal Group Leader in Lonza’s Drug Product Services Division, supporting DP Process Development.

Orla’s career to date in the pharmaceutical and biotech industry spans over 16 years working in the field of formulation and drug product development, with extensive experience in lyo cycle development, scale up and tech transfer while working in the USA with the world’s leading experts and pioneers in the field of freeze-drying.

Related Sessions:

Pharmaceutical Lyophilization
Summit 2019

Discuss best practices in tech & regulatory updates, process, formulation, testing, monitoring and new products development.
  • 13 Feb 2019
  • Prague, CZ
  • Pharma
Day 1: Wednesday, 13 February 2019
CASE STUDY: Scale-Up, Process Transfer and Improving Predictive Outcome for Lyophilized Drug Product.
  • Key considerations in Scale-up of a Freeze-Drying Cycle
  • Review of advancements in the Industry over the last 15 years
  • Case Study: ‘Development Scale to Pilot Scale and Beyond’
View Details